-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Underweight on Agilon Health, Raises Price Target to $3

Benzinga·05/08/2025 16:27:38
Listen to the news
Barclays analyst Andrew Mok maintains Agilon Health (NYSE:AGL) with a Underweight and raises the price target from $2 to $3.